Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

甲磺酸伊马替尼（格列卫）治疗弥漫性皮肤系统性硬化症：一项为期1年的IIa期单臂开放标签临床试验结果